SFI
SLS icon

Susquehanna Fundamental Investments’s SELLAS Life Sciences SLS Stock Holding History

Susquehanna Fundamental Investments’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$78K Sell
11,706
-10,744
-48% -$62.8K ﹤0.01% 1474
2021
Q4 		$124K Sell
22,450
-5,930
-21% -$44.9K ﹤0.01% 1314
2021
Q3 		$260K Buy
+28,380
New +$263K ﹤0.01% 1449

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EH
Equitable Holdings New York $15.5B AUM 19.09% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna Fundamental Investments's SLS Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its SELLAS Life Sciences (SLS) stake by 48% in Q1 2022, selling an estimated $62.8K and leaving 11,706 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

Susquehanna Fundamental Investments first reported a position in SLS in Q3 2021 and has held it in 3 quarters since. The position peaked at $260K in Q3 2021. 26 funds tracked by Wall St. Rank hold SLS as of Q1 2022.

  • Susquehanna Fundamental Investments held 11,706 shares of SELLAS Life Sciences worth $78K as of Q1 2022.
  • Susquehanna Fundamental Investments sold 10,744 SELLAS Life Sciences shares in Q1 2022, an estimated $62.8K.
  • SELLAS Life Sciences made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1474 holding.
  • Susquehanna Fundamental Investments first reported a position in SELLAS Life Sciences in Q3 2021 and has held it in 3 quarters since.
  • Susquehanna Fundamental Investments's SELLAS Life Sciences position peaked at $260K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.